TCT PAP STAINING REAGENT KIT

Cervical Cancer Screening TCT PAP STAINING REAGENT KIT

Product Introduction

TCT examination is the abbreviation of liquid-based thin-layer cell detection. Using a liquid-based thin-layer cell detection system to detect cervical cells and carry out cytological classification diagnosis. Compared with the film examination, the satisfaction of the specimen and the detection rate of abnormal cervical cells were significantly improved. At the same time, some precancerous lesions and microbial infections such as molds, trichomoniasis, viruses, and chlamydia can also be found.

Advantages

• KISSH provides optional components for all consumables for the test according to lab requirements, from sample collecting, sample transfer, slide preparation and staining process.

• KISSH Cell Preservation Solution is with high quality which ensuring cell morphology and structure integrity; Containing mucus-eliminating ingredients that can avoid interference, high-quality reproducible production of the same specimen.

• KISSH PAP Staining Reagent provides bright and transparent Cytoplasm after staining, clear structure of nuclear membrane, nucleolus and chromatin; It’s also suitable for both gynecological cytology smear staining and non-gynecological cell samples such as pleural effusion, ascites, and sputum.

• Glass slide provided is Cytology special slides, it’s with strong adhesion cell effect after special treatment, effectively avoiding delamination; also good light transmittance, without chromatic aberration.

PAP Staining Method

• Add hematoxylin and rinse three times with pure water after 90 seconds
• Add the buffer and rinse three times with pure water after 2 min
• Add the buffer and rinse three times with absolute ethanol after 2 min
• Add Pap staining solution and rinse 3 times with absolute ethanol after 7 min

Product Information

Shenzhen Kisshealh Biotechnology Co., Ltd., located in the Pingshan District, Shenzhen, P.R. China. is a diagnostics company focused on the development and manufacture of IVD tests at the Point-of-Care with highly innovative proprietary technology.

We focused on the emerging markets of in vitro pathological diagnosis and immunodiagnosis. We developed, manufactured and successfully launched the in vitro immunodiagnosis platform for cancer and the POCT for infectious, genetic and chronic diseases.

<span style="color: rgb(33, 33, 33); text-transform: none; text-indent: 0px; letter-spacing: normal;" initial;"="" initial;="" 0px;="" normal;="" 255);="" 255,="" rgb(255,="" 2;="" !important;="" inline="" none;="" 600;="" 14px;="" sans-serif;="" arial,="" roboto,="" w3",="" gb="" sans="" "hiragino="" gb",="" hei",="" micro="" "wenquanyi="" sans",="" "droid="" arimo,="" freesans,="" yahei",="" "microsoft="" helvetica,="" grande",="" "lucida="" ui",="" segoe="">At Kissh we work every day to shape the future of in-vitro diagnostic testing. And our people are our best asset, the reason for our track record and our strength while we are moving forward. We live by our fundamental values and incorporate them in everything that we do. Our best asset is ‘Step Forward Every Second’